The Acute Effect of "Exercise Snacks" on Glycemic Responses in Individuals With Type 2 Diabetes.

NCT ID: NCT06382246

Last Updated: 2024-05-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-20

Study Completion Date

2025-07-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To conduct a randomized crossover trial to determine the acute impact of exercise snacks on glycemic control in physically inactive individuals living with type 2 diabetes using continuous glucose monitoring.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will perform two, 48-hour experimental conditions separated by 24 hours while wearing a continuous glucose monitor to measure glycemic responses. The order of the trials will be randomized for each participant. The two trials will include an exercise condition (EX) and a control, non-exercise condition (CON). During the EX trial, participants will perform four exercise snacks per day on two consecutive days (i.e., Monday and Tuesday). Each exercise snack will be 1-minute in duration and consist of bodyweight style exercise performed with vigorous effort. During the CON trial, participants will be asked to refrain from any structured exercise during two consecutive days (i.e., Thursday and Friday). All meals will be provided to participants during the two 48-hour trials and will be standardized for a given participant. There will be a one-day wash out period in between the completion of both trials for all participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Randomized controlled crossover design
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exercise (EX): exercise snacks condition

Bodyweight-style exercise snacks lasting 1-minute each performed with vigorous effort 4 times per day on two consecutive days.

Group Type EXPERIMENTAL

Exercise snacks

Intervention Type OTHER

Bodyweight-style exercise snacks lasting 1-minute each performed with vigorous effort 4 times per day on two consecutive days.

Control (CON): Non-exercise condition

No structured exercise on two consecutive days.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise snacks

Bodyweight-style exercise snacks lasting 1-minute each performed with vigorous effort 4 times per day on two consecutive days.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 30-75 years old.
* Have physician-diagnosed type 2 diabetes.
* Currently participating in less than 150 minutes of moderate-to-vigorous intensity aerobic exercise per week.
* Have a body mass index between 18.5 and 40 kg/m2.
* Have had a stable medication dosage and no changes to the number of prescribed medications for at least 6 months.
* Able to maintain current medication doses during the study.
* Able to maintain current physical activity patterns during the study.
* HbA1c is less than or equal to 8.5%.
* Have access to a computer, tablet, or smartphone for intervention delivery and tracking.
* Can travel to McMaster University for in-person laboratory testing visits.
* Can read, write, and understand English.
* Anticipate having access to the internet for the duration of the intervention (i.e., over the next 3-4 months).
* Cleared for exercise participation based on the CSEP Get Active Questionnaire and the Rose Angina Questionnaire.

Exclusion Criteria

* Taking 4 or more glucose-lowering medications.
* Taking insulin.
* Taking beta-blockers.
* Taking 3 or more commonly prescribed medications for the prevention of cardiovascular disease (e.g., statins, antihypertensives).
* Have had an episode of severe hypoglycemia in the past 6 months (defined as having neurological symptoms consistent with neuroglycopenia and required assistance in treatment by a second party).
* Currently a cigarette smoker.
* Have a chronic musculoskeletal condition that would prevent participation in exercise.
* Have had a recent (within the last 2 years) cardiovascular event that prevents participation in exercise.
* Experience angina upon exertion.
* Have uncontrolled high blood pressure (hypertension) or an atypical blood pressure or pulse rate at rest or during exercise as determined by a physician.
* Have a scheduled surgical procedure within the next 3-4 months that would prevent exercise participation.
* Currently diagnosed with a cardiac or pulmonary disease (e.g., angina, arrythmia, exercise-induced bronchospasm) that would prevent exercise participation.
* Have a psychiatric disorder that could prevent you from completing the study procedures or visits.
* Have donated more than 0.5 L of blood within the last 4 weeks.
* Currently following an extreme diet (e.g., very low carbohydrate/calorie, ketogenic) or taking dietary/nutritional supplements that impact glucose control (e.g., exogenous ketones).
* Currently have diabetic ulcers, peripheral vascular disease, or diabetic neuropathy that will prevent participation in exercise.
* Currently on dialysis.
* Currently participating in another clinical trial that interferes with the study procedures.
* Currently pregnant or planning on becoming pregnant during the intervention (i.e., within the next 3-4 months).
Minimum Eligible Age

30 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

McMaster University

OTHER

Sponsor Role collaborator

University of British Columbia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jonathan Little

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonathan Little, PhD

Role: PRINCIPAL_INVESTIGATOR

University of British Columbia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of British Columbia Okanagan

Kelowna, British Columbia, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jonathan P Little, PhD

Role: CONTACT

250.807.9876

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jonathan Little, PhD

Role: primary

2508079876

Role: backup

2508079876

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H24-Acute-ExSnacks

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Breakfast Study
NCT05986097 COMPLETED PHASE1/PHASE2